Amanote Research
Register
Sign In
PReS13-SPK-1028: Activity and Damage - We Have to Measure Them
Pediatric Rheumatology
- United Kingdom
doi 10.1186/1546-0096-11-s2-i22
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Date
December 1, 2013
Authors
H Brunner
Publisher
Springer Science and Business Media LLC
Related search
Acute Stroke: We Have the Treatments and We Have the Evidence – We Need to Use Them
Critical Care
Critical Care
Intensive Care Medicine
PReS13-SPK-1107: Development of an Academic Pediatric Rheumatology Program
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
PReS13-SPK-1472: Science of Muscle Training in Inflammatory Disease
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Controlling Hypertension: We Have the Tools—We Just Need to Use Them
Journal of General Internal Medicine
Internal Medicine
Cortical Anomalies in Response to RGC Damage: How Do They Affect the Visual Field and How Should We Measure Them?
Acta Ophthalmologica
Medicine
Ophthalmology
LDL Apheresis or PCSK9 Inhibition? Sometimes We Have to Combine Them
Vessel Plus
Oxidative Damage to DNA: Do We Have a Reliable Biomarker?
Environmental Health Perspectives
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
The Schools We Need and Why We Don’t Have Them, by E.D. Hirsch, Jr.
Journal of Catholic Education
PReS13-SPK-1408: New EU Scientific Guidelines for JIA, SLE and GIOP From the European Medicines Agency
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health